Research & Publications
Developmental therapeutics, designing clinical trials in multiple myeloma, with specific interests in advanced imaging, tumor heterogeneity and tumor resistance in myeloma, as well as strategies for advancing maintenance therapy, and eradication of minimal residual disease in multiple myeloma.
Amyloidosis; Hematology; Leukemia, Plasma Cell; Waldenstrom Macroglobulinemia; Multiple Myeloma; Myeloma Proteins; Paraproteinemias; Neoplasms, Plasma Cell; Smoldering Multiple Myeloma
- Understanding the role of Natural Killer T (NKT) cells in hematologic malignancies: progress and challenges.Neparidze N and Dhodapkar, MV. Chapter. Natural Killer T Cells. Cancer Drug Discovery and Development 2012, pp 153-167